Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias
Sita Bhella, Gerard Agbayani, Katrina Hueniken, Abi Vijenthira et autres
ABSTRACT: Plasma cell dyscrasias (PCD) are a group of hematologic disorders associated with immune dysfunction from underlying disease and/or treatment. With the continued circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), optimizing and maintaining durable protection in this vulnerable population through …
ca, us (code pays fourni par la source)
0 citations
Blood Advances